Search

Search Results
Results 17561 - 17570 of 18846 for breast cancer
  • Drug - 12 Nov 2025
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.
  • Drug - 10 Nov 2025
    Consumer Medicine Information (CMI) about Mylotarg intended for persons living in Australia.
  • News - 6 Nov 2025
    When Linda Moslow, A16P, A18P, entered perimenopause in her early 40s, she was blindsided. "I'd always been healthy and grounded in wellness," she says. "Suddenly, I couldn't recognize myself." The...
  • News - 6 Nov 2025
    Two new studies being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) show that people with allergic conditions - including eczema,...
  • Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Gardasil 9 intended for persons living in Australia.
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Bavencio intended for persons living in Australia.
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Tafinlar intended for persons living in Australia.
  • Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Mekinist intended for persons living in Australia.
  • White Paper - 9 Oct 2025
    Enhance the accuracy and efficiency of your cytotoxicity assays with Incucyte’s real-time imaging platform.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.